GHK-Cu Results: Before and After at 4, 8, 12 Weeks

Key takeaways

• There are no GHK-Cu before-and-after results with controlled data behind them for injections, and the topical data are a handful of 12-week studies in 41 to 71 women that reported end-of-study results without numbers, summarized by the peptide's inventor. This page is built from those, two wound trials and one negative post-laser study.
• Week 4: the only early data point is a one-month biopsy pilot in which collagen rose in 70 percent of women on a copper peptide cream versus 50 percent on vitamin C and 40 percent on retinoic acid; it was never published in full. Week 8: no cosmetic study reported a result. Week 12: fewer fine lines and firmer, thicker skin in three industry studies, and no objective change in a 13-patient blinded study after laser resurfacing.
• Hair: one 18-person split-face study of a 2 percent serum reported more and thicker eyebrow hairs at 12 weeks. There is no scalp trial in pattern hair loss and no injection data for hair at any time point.
• Before-and-after photos cannot separate copper from lighting, angle, hydration, filters, a retinoid started the same month, or the seller's incentive; in the laser study, patients rated their skin better while blinded evaluators and software saw no difference.
• A fair self-test is twelve weeks, one new product, the same camera, light and angle every four weeks, and a stop rule: a spreading rash, stinging that does not settle, or nothing to see at week 12.

GHK-Cu results, honestly stated, are a 12-week story with a thin middle: the topical studies that found anything measured it at the end of three months, nothing was reported at week 8, and the one early data point is a one-month collagen pilot. Everything else online is photographs. This page lays out what the studies measured and when, what the photos can and cannot show, and how to run a fair test on your own face. The parent best peptides for skin guide ranks copper peptide against retinoids and the other cosmetic peptides, GHK-Cu injection versus topical explains why the injectable route has no results to report, and the GHK-Cu profile has the full evidence table, dosing and legal status.

What the studies measured, and when

Topical only. No human study of injected GHK-Cu on its own exists, so the injection column of any timeline is blank at every week.

Grades follow our editorial policy. The cosmetic rows rest on the inventor's description of studies that were never published in full (Pickart 2015), which the 2026 independent evidence map characterizes as small or incompletely characterized (Mateescu 2026). A second systematic review, published in a plastic-surgery journal in August 2026, counted 20 eligible studies of GHK-Cu alone for aesthetic uses, 18 of them preclinical and only 2 randomized trials in people (Mokhtar 2026). A 2025 pharmaceutics review was blunter, noting a surprising absence of clinical studies of GHK-Cu and its palmitoylated cousin as anti-wrinkle agents despite their wide use in anti-wrinkle products (Mortazavi 2025).

Week by week, in plain English

Weeks one and two. Nothing was measured and nothing visible should be expected. This is the tolerance window: stinging or redness usually comes from the vehicle or from layering copper peptide with strong acids or high-dose vitamin C, and a rash spreading beyond the application area is the sign of copper contact allergy. A patch test on the inner forearm first, as the American Academy of Dermatology advises for any new product, shortens this stage (AAD, wrinkle remedies).

Week four. The single early data point is a biopsy pilot, not a mirror: after one month of creams on the thighs of women around 50, collagen increased in 70 percent of those using the copper peptide cream, against 50 percent with vitamin C and 40 percent with retinoic acid (Pickart 2015). That is a laboratory stain, in an unknown number of women, in a study that never reached a journal, and it says nothing about what anyone saw.

Week eight. A blank. None of the facial studies reported a mid-point, so there is no evidence that anything visible happens at two months and none that it does not. The AAD's window for any anti-aging product, six weeks to three months, puts week eight at the early edge (AAD, wrinkle remedies).

Week twelve. The endpoint of every cosmetic study and the first point at which the literature reports anything a person could notice: fewer fine lines and wrinkles, less laxity, and greater density and thickness in the 71-woman and 41-woman studies, plus more keratinocyte proliferation on biopsy in the 67-woman twice-daily study (Pickart 2015). None reports an effect size, so how much is not knowable from the record. The counterweight is the one 12-week study run by surgeons with blinded assessment: after laser resurfacing, computer analysis and blinded evaluators found no difference in redness, wrinkles or skin quality between regimens, while the patients using the copper peptide rated their skin quality better on a questionnaire (Miller 2006).

After week twelve. No cosmetic study continued and none followed participants after stopping, so whether the changes persist, plateau or fade is unmeasured. The next real data point is a registered 60-person, vehicle-controlled split-wound trial of a 0.1 percent GHK-Cu gel, started in February 2026 and recruiting, with results expected in 2027 (NCT07437586); its registration is not a result.

The wound trials cut both ways

The strongest human result GHK-Cu has produced is also the oldest: in a multicenter, randomized, evaluator-blinded trial, a daily copper peptide gel applied after sharp debridement of diabetic foot ulcers achieved a median 98.5 percent closure versus 60.8 percent with vehicle, healed about three times faster, and cut ulcer infections from 34 to 7 percent (Mulder 1994). It was never replicated and the product was not developed. Two years earlier, in 86 patients with venous leg ulcers, a 0.4 percent copper peptide cream did no better than placebo while silver sulfadiazine beat both (Bishop 1992). Marketing cites the first and omits the second. Neither is a skin-appearance result, and neither abstract states how many weeks it ran, which is why they sit outside the week-by-week table.

Hair results

Hair is the fastest-growing GHK-Cu claim and the thinnest. The only human data are the 2026 split-face study: 18 adults applied a 2 percent GHK-Cu serum to one eyebrow and vehicle to the other for 12 weeks, and the treated side had more and thicker hairs, without the study defining what form of the complex reached the skin (Mateescu 2026). That is an eyebrow result, not a scalp trial; there is no study in pattern hair loss, no comparison with minoxidil, and no injection data for hair at any week. The photos filed under copper peptide injections for hair growth are the least evidential of all, because the people posting them are usually injecting a GLOW or KLOW blend and often using minoxidil at the same time; the GLOW and KLOW page explains why the blend cannot be credited with anything.

What before-and-after photos show, and why they are not evidence

A photo pair proves that two photographs were taken. The things that change a photograph more reliably than any ingredient are the light and its angle, the distance to the lens, the time of day, hydration, makeup, the camera's processing and any filter, and the expression. Then come the confounders of real life (the retinoid or sunscreen started the same month, the vacation), the statistics (a bad-skin week photographed as the before, after which skin regresses toward its average), and the incentive: most copper peptide photos are posted by someone selling it.

The GHK-Cu literature contains its own demonstration. In the post-laser study, the people using the copper peptide products were sure their skin was better and said so on a validated questionnaire; blinded evaluators and software, looking at the same faces, saw no difference (Miller 2006). A before-and-after photo is expectation with a date stamp. No published GHK-Cu study used photographs as its outcome measure, which should settle how much weight to give them.

Realistic expectations

If a topical copper peptide works for you, the record suggests this: nothing in the first month beyond tolerance, and at three months a modest reduction in fine lines and a slight gain in firmness that a careful observer might see in matched photographs and a casual one might not. It will not change established wrinkles, replace a retinoid or do anything a sunscreen does, and the injectable version of this timeline is blank at every week.

How to run a fair self-test

Borrow the studies' one good habit: fixed conditions and a fixed endpoint.

1. Change one thing. Add the copper peptide to a routine you have kept stable for a month and change nothing else for 12 weeks: same cleanser, same sunscreen, same retinoid if you use one. The AAD's advice to limit the number of products exists for this reason (AAD, wrinkle remedies).
2. Patch test, then start. Inner forearm for a few days before the face.
3. Photograph like a trial. Same room, same light (window light at the same hour, or the same lamp), no flash, same distance and angle, three views, no makeup, no filter, a neutral expression. Take the set before the first application and at weeks 4, 8 and 12.
4. Use it as studied. Once or twice daily, at a different time of day from strong acids or high-dose vitamin C.
5. Judge blind, at week 12. Shuffle the sets and have someone who does not know the order pick the better skin, or compare them yourself before checking the dates. Nothing in the literature reports a visible result earlier or says what happens later.

When to stop

• A rash spreading beyond where the product went on, at any point: copper contact allergy, and a reason to stop for good.
• Stinging or burning that does not settle within days. The AAD's rule is to stop any product that stings or burns unless a dermatologist prescribed it (AAD, wrinkle remedies); try separating it from acids first.
• Nothing to see at week 12. The studies had found what they found by then; continuing past three months is a bet with no data on either side.
• Pregnancy or breastfeeding. No data for a cosmetic with a copper ion in it; the profile explains the sensible default.
• The urge to switch to injections because the cream was slow. The injection has no results at any week, cannot be legally compounded, and carries the copper load the cream keeps out; see GHK-Cu injection versus topical.

Bottom line

GHK-Cu results, as the studies describe them, are modest and arrive at twelve weeks: fewer fine lines and firmer, slightly thicker skin in three small industry studies that never published their numbers, no objective change in the one blinded study, one positive and one negative wound trial, and twelve weeks of eyebrows. Nothing is reported at week eight, and nothing after week twelve. The photographs online add expectation and lighting to that record, not evidence. Run your own twelve-week test under fixed conditions, judge it at the end, and spend the rest on sunscreen.

Frequently asked questions

+−How long does GHK-Cu take to work?

The studies that found something found it at 12 weeks, because that is when they looked: the three facial and eye-cream studies reported fewer fine lines and firmer, thicker skin at the end of 12 weeks of daily use and gave no earlier time point. The only earlier data are a one-month biopsy pilot in which collagen rose in more women on the copper peptide cream than on vitamin C or retinoic acid. The American Academy of Dermatology tells patients to allow six weeks to three months for any anti-aging product. Expect nothing visible in the first month and judge at week 12.

+−What results can you expect from GHK-Cu?

From a topical product, modest ones: in 12-week industry studies of 41 to 71 women, fewer fine lines and wrinkles, less laxity, and greater skin density and thickness, without published effect sizes, and in a blinded 13-patient study after laser resurfacing, no objective difference at all. The 2026 independent review calls the compound promising but unproven. Think of it as comparable to other active cosmetic ingredients, and smaller than a retinoid. From an injection, nothing can be expected, because nothing has been measured.

+−Does GHK-Cu work for hair growth?

One study says something: a 2026 randomized, vehicle-controlled split-face study in 18 people found more and thicker eyebrow hairs after 12 weeks of a 2 percent GHK-Cu serum. That is eyebrows, not scalp, and the study did not define what form of the peptide reached the skin. There is no trial of GHK-Cu in men or women with pattern hair loss, and no injection study for hair at any time point. Minoxidil has decades of controlled trials.

+−Are GHK-Cu before and after photos real?

Some are real photographs; none are evidence. No published GHK-Cu study used photographs as its outcome, and photos online come without a control, a dose, a date, or any statement of what else changed. Lighting, angle, hydration, makeup, filters and a retinoid started the same month can each produce a 'result' on their own. The post-laser study is the warning: patients who used the copper peptide rated their skin better, while blinded evaluators and computer analysis found no difference between groups.

+−Does GHK-Cu tighten skin or build collagen?

In cells and rats, GHK-Cu reliably stimulates collagen and other matrix; that is the biology behind every copper peptide product. In people the evidence is a one-month pilot in which collagen on thigh biopsies increased in 70 percent of women on the cream versus 50 percent on vitamin C and 40 percent on retinoic acid, with no participant number reported, and the 12-week studies' reports of greater skin density and thickness. Tighten is a strong word for what those studies describe; firmer and slightly thicker over three months is closer to the data.

+−How often should you use GHK-Cu?

Once or twice daily is what the studies used: twice daily in the 67-woman facial study, twice daily in the 2026 eyebrow study, once daily in the diabetic ulcer trial and the registered wound trial. No study compares frequencies or concentrations, so a more-is-better approach has no data behind it. Apply it at a different time of day from strong acids or high-dose vitamin C, patch test first, and stop if a rash spreads beyond where it went on.

+−What happens when you stop using copper peptides?

No study has followed anyone after stopping, so the honest answer is unknown. The longest cosmetic studies ran 12 weeks and reported their results on the last day. Cosmetic changes in skin surface and hydration generally fade when the product does, and there is no mechanism by which a topical would lock in a permanent change, but nobody has measured the time course for GHK-Cu.

+−Is there a GHK-Cu injection before and after for hair growth?

Not one with data. No human study of injected GHK-Cu exists for hair, skin or anything else, and the photos posted under that search term are uncontrolled and usually involve GLOW or KLOW blends with other compounds, topical products, or minoxidil at the same time. Injectable GHK-Cu also cannot be legally compounded in the United States as of October 2026. The injection versus topical page covers why the route does not rescue the evidence.

Sources

1. ReviewPickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int 2015;2015:648108. (Authors are the inventor and his company; describes the Abdulghani 1998, Leyden 2002 and Finkley 2005 cosmetic studies.) (2015)
2. ReviewMateescu DM et al. GHK-Cu as a bioactive metallopeptide and drug-delivery cargo: coordination chemistry, formulation science, therapeutic evidence, and a translational roadmap (systematic evidence-mapping review). Pharmaceutics 2026;18:1077. (2026)
3. StudyMulder GD et al. Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-L-histidyl-L-lysine copper. Wound Repair Regen 1994;2:259-69. (1994)
4. StudyBishop JB et al. A prospective randomized evaluator-blinded trial of two potential wound healing agents for the treatment of venous stasis ulcers. J Vasc Surg 1992;16:251-7. (1992)
5. StudyMiller TR, Wagner JD, Baack BR, Eisbach KJ. Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin. Arch Facial Plast Surg 2006;8:252-9. (2006)
6. ReviewMokhtar J et al. The regenerative potential of GHK-Cu in aesthetic medicine (systematic review: 20 studies, 18 preclinical, 2 randomized trials). Aesthet Surg J 2026; published online August 20, 2026. (2026)
7. ReviewMortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically applied GHK as an anti-wrinkle peptide: advantages, problems and prospective. Bioimpacts 2025;15:30071. (2025)
8. SourceClinicalTrials.gov NCT07437586. A phase 2, randomized, double-blind, vehicle-controlled, split-wound study of topical GHK-Cu gel (0.1 percent) in healthy adults; sponsor Hudson Biotech; started February 2026, recruiting. (2026)
9. GuidelineAmerican Academy of Dermatology. Wrinkle remedies. Patient page (patch testing, limiting the number of products, stopping products that sting or burn, allowing six weeks to three months for results).